Keener Financial Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$735K Sell
613
-29
-5% -$29.6K 0.26% 23
2026
Q1
$590K Hold
642
0.25% 25
2025
Q4
$689K Sell
642
-22
-3% -$21K 0.3% 20
2025
Q3
$506K Hold
664
0.23% 26
2025
Q2
$517K Hold
664
0.26% 24
2025
Q1
$548K Buy
664
+130
+24% +$108K 0.36% 19
2024
Q4
$412K Hold
534
0.24% 29
2024
Q3
$473K Hold
534
0.31% 24
2024
Q2
$483K Hold
534
0.32% 24
2024
Q1
$416K Hold
534
0.29% 25
2023
Q4
$311K Buy
+534
New +$312K 0.24% 27

Other funds holding LLY

Keener Financial Planning's LLY Position: Q2 2026 in Review

Keener Financial Planning reduced its Eli Lilly (LLY) stake by 4.5% in Q2 2026, selling an estimated $29.6K and leaving 613 shares worth $735K. The position accounts for 0.26% of the portfolio, ranked #23.

Keener Financial Planning first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Keener Financial Planning held 613 shares of Eli Lilly worth $735K as of Q2 2026.
  • Keener Financial Planning sold 29 Eli Lilly shares in Q2 2026, an estimated $29.6K.
  • Eli Lilly made up 0.26% of Keener Financial Planning's portfolio in Q2 2026, its #23 holding.
  • Keener Financial Planning first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Keener Financial Planning's 13F filing for Q2 2026, filed 31 Jul 2026.